The presence of increased circulating levels of TNF-α and IL-6 in patients with cirrhosis without infections was described decades ago [21, 22], but comprehensive characterization of these inflammatory mediators in ACLF and their correlation with disease severity and organ failures were described more recently [4, 5]. Here, IL6 is linked to Cirrhosis.